Acquiring signalling specificity from the cytokine receptor gp130

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• A limited set of intracellular signaling molecules mediate diverse cellular responses to growth factors and cytokines.
• Understanding these signaling mechanisms is crucial for deciphering cell-type-specific responses.
• The interleukin-6 (IL-6) family of cytokines utilizes the common receptor subunit gp130.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying gp130 signaling.
• To identify how differential signaling pathways contribute to specific cellular responses.
• To understand how cells integrate conflicting signals to maintain homeostasis.

Main Methods:

• Phenotypic comparison of genetically modified mice: amino acid knock-in substitutions, knockout models, and transgenic models of gp130.
• Analysis of signaling pathways including STAT1/3 and SHP2/ERK.
• Investigation of target-gene responsiveness and pathway integration.

Main Results:

• Identified two primary gp130 signaling mechanisms: differential target-gene responsiveness to signaling thresholds and cellular integration of conflicting pathway information.
• Demonstrated reciprocal negative regulation between STAT1/3 and SHP2/ERK cascades, accounting for most intracellular gp130 signaling.
• Highlighted the role of specific cell types in integrating signals to prevent pathological outcomes.

Conclusions:

• gp130 signaling relies on distinct molecular mechanisms involving STAT1/3 and SHP2/ERK pathways.
• Cellular capacity to integrate signaling information is critical for preventing aberrant responses.
• These findings provide insights into cytokine signaling and its role in health and disease.